Final Trade: DEO, ADP, AAPL, INSM
The final trades of the day with CNBC’s Melissa Lee and the ‘Fast Money’ traders.
Archived explainer. For the current picture see today's INSM page.
INSMED INC (INSM) is up +20.58% in the latest session. Our newswire has captured 25 stories on INSM across 11 sources in the last 36 hours, with AI sentiment reading bullish (avg 64/100).
Insmed Inc (INSM) shares surged 20.58% to close at $144.46, driven by reports that Sanofi SA is considering an acquisition of the biopharmaceutical company. The move reflects growing speculation about a potential takeover, with analysts suggesting the deal could offer significant strategic value and a substantial premium to current market prices.
Reports emerged that Sanofi SA is weighing a takeover of Insmed, a US drugmaker. This development sparked immediate interest in the stock, leading to a sharp intraday rally. BMO Capital analyst Conor MacKay noted that an acquisition makes considerable strategic sense for Sanofi. Meanwhile, RBC analysts rated the stock Outperform, estimating that a takeover could value shares between $170 and $210, implying a premium of 20% to 50%. Raymond James also highlighted the strategic value of Insmed amid the rumored bid.
The broader healthcare sector faced headwinds during the same session, with the NYSE Healthcare Index falling 2.1% and the State Street Health Care Select Sector SPDR ETF dropping 1.7%. Despite the sector-wide decline, Insmed bucked the trend due to the specific M&A speculation. The news was widely disseminated, with multiple financial outlets covering the potential deal and analyst reactions.
The stock’s 52-week range spans from $90.39 to $212.75, and the recent price action contributed to 12 fresh 52-week highs printed on November 19, 2026. Over the last eight sessions, the stock has moved up 20.9%, rising from $119.49 to its current level. Fundamentally, Insmed remains unprofitable with a trailing twelve-month EPS of -$2.80 and a net margin of -39.9%, though revenue has grown 240.0% year-over-year. The company has a market capitalization of $26.7 billion and a beta of 0.81.
Retail sentiment appears to be improving, with social chatter showing three posts in the last 24 hours and three in the last seven days. Recent insider filings show one sale totaling $3.1 million by director David R. Brennan in September 2026. Congressional disclosures indicate Donald J. Trump bought between $15,001 and $50,000 in July 2026 and sold between $1,001 and $15,000 in June 2026.
Investors will monitor further developments regarding the potential Sanofi acquisition and any official statements from either company. Additionally, the breadth of analyst coverage, which currently includes 25 stories from 11 sources in the last 36 hours, suggests continued high visibility and potential volatility as the deal speculation evolves.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
The final trades of the day with CNBC’s Melissa Lee and the ‘Fast Money’ traders.
On November 19, 2026, shares of Insmed Inc (INSM) jumped 19% amid reports that Sanofi (SNY) is contemplating an acquisition of the biopharmaceutical company. Th
On November 19, 2026, reports surfaced that Sanofi SA (NASDAQ: SNY) is considering an acquisition of Insmed, a move that BMO Capital analyst Conor MacKay views
RBC analyst rates Insmed Outperform: a Sanofi takeover could value shares at $170-$210, with a 20%-50% premium plausible.
Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index falling 2.1% and the State Street Health Care Select Sector SPDR ETF dropping 1.7%. The iShares Biotechnology ETF shed 0.1%. In corporate news, Sanofi (SNY.NaE) is mulling an acquisition of US drugmaker Insmed (INSM.NaE), Bloomberg reported.
More on INSM: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier INSM move explainers: 2026-11-20 · 2026-11-19 · 2026-10-30 · 2026-10-29 · 2026-10-06 · 2026-10-05 · 2026-08-07 · 2026-08-06